Buy CRESEMBA 200 MG ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE

Cresemba 200 mg is an antifungal medication used to treat serious fungal infections. This intravenous powder for solution contains isavuconazole (isavuconazonium sulfate) and is manufactured by Avir Pharma Inc. in Canada.

Strength

200 MG

Manufacturer / TM Owner

AVIR PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Cresemba 200 mg is primarily used for the treatment of invasive aspergillosis and mucormycosis, which are serious fungal infections. It works by stopping the growth of fungi. This medication is often prescribed when other treatments have not been effective or are not suitable. Cresemba is designed for intravenous administration, providing a direct route for the antifungal agent to enter the bloodstream.

Side Effects

Common effects of Cresemba 200 mg may include headache, nausea, vomiting, and diarrhea. Some individuals might experience changes in taste or liver function tests. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen. The medication is designed to target fungal infections, but individual responses can vary.

Precautions & Warnings

Cresemba 200 mg should be used with caution in patients with liver disease or a history of liver problems. It is important to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about all other medications they are taking to avoid potential interactions. Proper handling and storage of the medication are essential to maintain its effectiveness.

Avoid Interactions

Cresemba 200 mg may interact with other medications, including those metabolized by the liver enzymes CYP3A4. This can affect the effectiveness of both Cresemba and the other medications. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain over-the-counter medications may also interact with Cresemba, so it's advisable to consult a healthcare professional before starting any new treatments.

References

Frequently Asked Questions

Cresemba 200 mg is used to treat serious fungal infections, such as invasive aspergillosis and mucormycosis.

Cresemba 200 mg is administered intravenously as a powder for solution.

Common side effects may include headache, nausea, vomiting, and diarrhea.

Cresemba 200 mg may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Cresemba 200 mg is manufactured by Avir Pharma Inc. in Canada.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.